SVRA
Savara Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +14.3% ·
share flow -2.3% ·
net new positions +12.5%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -4 | 57.38M | $353.31M | +4 | −8 |
| Q1 2026 | 80 | +17 | 56.36M | $307.68M | +21 | −4 |
| Q4 2025 | 62 | -1 | 53.03M | $319.78M | +1 | −2 |
| Q3 2025 | 16 | +2 | 30.07M | $107.34M | +2 | n/a |
| Q2 2025 | 11 | -1 | 28.07M | $64.00M | n/a | −1 |
| Q1 2025 | 9 | -2 | 11.30M | $31.31M | n/a | −2 |
| Q4 2024 | 11 | +2 | 17.17M | $52.72M | +2 | n/a |
| Q3 2024 | 8 | -1 | 19.41M | $82.32M | +1 | −2 |
| Q2 2024 | 9 | n/a | 17.54M | $70.68M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 8.31M | -1.7% | $29.68M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 2 | Wellington Management ✦ | 2.64M | -21.1% | $9.44M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.36M | -4.0% | $8.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.92M | n/a | $6.85M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 5 | Goldman Sachs Group ✦ | 662.25K | n/a | $2.36M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 372.02K | +366.7% | $1.33M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 260.10K | New | $928,557 | 0.0% | New | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 127.67K | n/a | $455,782 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 67.42K | +21.1% | $241,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 7.20K | +27.4% | $25,711 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $928,557 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 185 holders, 212.23M shares, $1.16B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.